SNSE logo

Sensei Biotherapeutics (SNSE)

Profile

Full Name

Sensei Biotherapeutics, Inc.

Ticker Symbol

SNSE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 4, 2021

Indexes

Not included

Website

http://www.senseibio.com

Employees

14

Key Details

Price

$0.41(-3.02%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.20(+1.64% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.41
SNSE price is $0.41

30-Day Relative Volume

0.27
SNSE 30-day relative volume is 0.27

Price Performance

Price Today change

-3.02%
SNSE price is down -3.02% today

Price YTD change

-16.88%
SNSE price is down -16.88% since January 1st

Price 1-year change

-59.27%
SNSE price is down -59.27% year-on-year

Price 3-year change

-78.79%
SNSE price is down -78.79% over the past 3 years

Price Range

Price All-time high

$26.50
SNSE price is currently -98.46% below its historical high of $26.50

Price 3-year low

$0.25
SNSE price is currently +62.92% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$10.24M
SNSE market capitalization is $10.24 million

Market cap 3-year change

-82.61%
SNSE market capitalization is down -82.61% over the past 3 years

Market cap All-time high

$672.45M
SNSE market capitalization is currently -98.48% below its historical high of $672.45 million

Market cap sector rank

20.31%
SNSE market capitalization is higher than 20.31% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.31%
SNSE shares outstanding is up +0.31% year-on-year

Shares Outstanding 3-Year Change

-18.03%
SNSE shares outstanding is down -18.03% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.86
SNSE beta is 0.86

200-day SMA

$0.52
SNSE price is currently -21.58% below its 200-day simple moving average

50-day SMA

$0.43
SNSE price is currently -5.37% below its 50-day simple moving average

RSI

53.57
SNSE 14-day relative strength index is 53.57

Volume

0.27
SNSE 30-day relative volume is 0.27

ATR

$0.07
SNSE average true range is $0.07

10-day Historical Volatility

167.11%
SNSE 10-day historical volatility is 167.11%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
SNSE annual revenue value is unknown

Revenue Analysts estimate

-
SNSE annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
SNSE annual revenue 1-year change is unknown

Revenue Sector rank

-
SNSE annual revenue is unknown

EPS

EPS

-$1.20
SNSE annual earnings per share is -$1.20

EPS Analysts estimate

-$0.66
SNSE annual earnings per share is currently +81.82% higher than the consensus analysts' forecast

EPS 1-year change

+1.64%
SNSE annual earnings per share is up +1.64% year-on-year

EPS Sector rank

51.74%
SNSE annual earnings per share is higher than 51.74% of companies in Healthcare sector

Profit

Gross profit

-
SNSE annual gross profit value is unknown

Gross margin

-
SNSE annual gross profit margin value is unknown

Operating profit

-$31.66M
SNSE annual operating income is -$31.66 million

Operating margin

-
SNSE annual operating profit margin value is unknown

Net income

-$30.16M
SNSE annual net profit is -$30.16 million

Net margin

-
SNSE annual net profit margin value is unknown

Expenses

Total expenses

$31.66M
SNSE annual total expenses is $31.66 million

Operating expenses

$31.66M
SNSE annual total operating expenses is $31.66 million

Cost of goods sold

-
SNSE annual cost of goods sold value is unknown

Selling, general & administrative expenses

$13.04M
SNSE annual SGA is $13.04 million

Depreciation and amortization

$1.32M
SNSE annual depreciation & amortization is $1.32 million

Interest expense

$90.00K
SNSE annual interest expense is $90.00 thousand

Income tax

-
SNSE annual income tax value is unknown

EBIT & EBITDA

EBIT

-$30.07M
SNSE annual earnings before interest & taxes is -$30.07 million

EBITDA

-$28.75M
SNSE annual EBITDA is -$28.75 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$45.36M
SNSE annual total assets is $45.36 million

Non current assets

$3.43M
SNSE annual long term assets is $3.43 million

Current assets

$41.93M
SNSE annual total current assets is $41.93 million

Cash and cash equivalents

$9.99M
SNSE annual cash & cash equivalents is $9.99 million

Accounts receivable

-
SNSE annual accounts receivable value is unknown

Inventory

-
SNSE annual inventory value is unknown

Liabilities

Total liabilities

$6.97M
SNSE annual total liabilities is $6.97 million

Long term liabilities

$1.53M
SNSE annual total long term liabilities is $1.53 million

Current liabilities

$5.45M
SNSE annual total current liabilities is $5.45 million

Accounts payable

-
SNSE annual accounts payable value is unknown

Debt

Total debt

$3.85M
SNSE annual total debt is $3.85 million

Total debt 1-year change

-38.06%
SNSE annual total debt is down -38.06% year-on-year

Long term debt

$1.53M
SNSE annual long term debt is $1.53 million

Short term debt

$2.32M
SNSE annual short term debt is $2.32 million

Equity & Capital

Shareholders equity

$38.39M
SNSE annual stockholders equity is $38.39 million

Book value

$38.39M
SNSE annual book value is $38.39 million

Retained earnings

-$262.05M
SNSE annual retained earnings is -$262.05 million

Working capital

$36.48M
SNSE annual working capital is $36.48 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$24.67M
SNSE annual cash flow from operations is -$24.67 million

Cash from operations 1-year change

+22.96%
SNSE annual cash flow from operations is up +22.96% year-on-year

Cash from investing

$22.44M
SNSE annual cash flow from investing activities is $22.44 million

Cash from investing 1-year change

-41.58%
SNSE annual cash flow from investing activities is down -41.58% year-on-year

Cash from financing

-$787.00K
SNSE annual cash flow from financing activities is -$787.00 thousand

Cash from financing 1-year change

+92.96%
SNSE annual cash flow from financing activities is up +92.96% year-on-year

CAPEX

CAPEX

-
SNSE annual capital expenditures value is unknown

CAPEX 1-year change

-
SNSE annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$24.82M
SNSE annual free cash flow is -$24.82 million

Free cash flow 1-year change

+22.94%
SNSE annual free cash flow is up +22.94% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SNSE annual gross profit margin value is unknown

Operating margin

-
SNSE annual operating profit margin value is unknown

Net margin

-
SNSE annual net profit margin value is unknown

ROA & ROE

ROA

-66.48%
SNSE annual return on assets is -66.48%

ROE

-78.56%
SNSE annual return on equity is -78.56%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SNSE price to earnings ratio value is unknown

PE ratio Sector rank

-
SNSE price to earnings ratio is unknown

PB Ratio

PB ratio

0.27
SNSE price to book ratio is 0.27

PB ratio Sector rank

22.32%
SNSE price to book ratio is higher than 22.32% of companies in Healthcare sector

PS Ratio

PS ratio

-
SNSE price to sales ratio value is unknown

PS ratio Sector rank

-
SNSE price to sales ratio is unknown

Enterprise value

Enterprise value

$4.10M
SNSE enterprise value is $4.10 million

Enterprise value Sector rank

18.17%
SNSE enterprise value is higher than 18.17% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.14
SNSE EV/EBITDA is -0.14

EV/EBITDA Sector rank

60.17%
SNSE EV/EBITDA is higher than 60.17% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.70
SNSE annual current ratio is 7.70

Quick ratio

-
SNSE annual quick ratio value is unknown

Leverage

Debt to equity

0.10
SNSE annual debt to equity ratio is 0.10

Interest coverage ratio

-334.08
SNSE annual interest coverage ratio is -334.08

Risk & Stability

Piotroski F-Score

-
SNSE piotroski f-score value is unknown

Altman Z-Score

-
SNSE altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 28, 25 Oppenheimer
Outperform
Mar 28, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 8, 25 HC Wainwright & Co.
Buy
Aug 7, 24 HC Wainwright & Co.
Buy
May 24, 24 Stephens & Co.
Overweight
May 24, 24 HC Wainwright & Co.
Buy
May 14, 24 Stephens & Co.
Overweight
Dec 4, 23 HC Wainwright & Co.
Buy
Dec 13, 22 Citigroup
Buy

Institutional Ownership

Similar stocks

SSKN logo
STRATA Skin Sciences (SSKN)
NERV logo
Minerva Neurosciences (NERV)
RLYB logo
Rallybio (RLYB)
CODX logo
Co-Diagnostics (CODX)
TRIB logo
Trinity Biotech (TRIB)
EKSO logo
Ekso Bionics Holdings (EKSO)
MGRX logo
Mangoceuticals (MGRX)
BLRX logo
BioLineRx (BLRX)
HOTH logo
Hoth Therapeutics (HOTH)
  • What is the ticker symbol for Sensei Biotherapeutics?
  • Does Sensei Biotherapeutics pay dividends?
  • What sector is Sensei Biotherapeutics in?
  • What industry is Sensei Biotherapeutics in?
  • What country is Sensei Biotherapeutics based in?
  • When did Sensei Biotherapeutics go public?
  • Is Sensei Biotherapeutics in the S&P 500?
  • Is Sensei Biotherapeutics in the NASDAQ 100?
  • Is Sensei Biotherapeutics in the Dow Jones?
  • When was Sensei Biotherapeutics's last earnings report?
  • When does Sensei Biotherapeutics report earnings?
  • Should I buy Sensei Biotherapeutics stock now?

What is the ticker symbol for Sensei Biotherapeutics?

The ticker symbol for Sensei Biotherapeutics is NASDAQ:SNSE

Does Sensei Biotherapeutics pay dividends?

No, Sensei Biotherapeutics does not pay dividends

What sector is Sensei Biotherapeutics in?

Sensei Biotherapeutics is in the Healthcare sector

What industry is Sensei Biotherapeutics in?

Sensei Biotherapeutics is in the Biotechnology industry

What country is Sensei Biotherapeutics based in?

Sensei Biotherapeutics is headquartered in United States

When did Sensei Biotherapeutics go public?

Sensei Biotherapeutics's initial public offering (IPO) was on February 4, 2021

Is Sensei Biotherapeutics in the S&P 500?

No, Sensei Biotherapeutics is not included in the S&P 500 index

Is Sensei Biotherapeutics in the NASDAQ 100?

No, Sensei Biotherapeutics is not included in the NASDAQ 100 index

Is Sensei Biotherapeutics in the Dow Jones?

No, Sensei Biotherapeutics is not included in the Dow Jones index

When was Sensei Biotherapeutics's last earnings report?

Sensei Biotherapeutics's most recent earnings report was on Mar 28, 2025

When does Sensei Biotherapeutics report earnings?

The next expected earnings date for Sensei Biotherapeutics is May 9, 2025

Should I buy Sensei Biotherapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page